Science & Co review
Declares in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two disclosures most of this market never makes.
- Semaglutide
- $149/mo month-to-month; $79 only on a twelve-month plan
- Tirzepatide
- $199/mo month-to-month; $125 only on a twelve-month plan
- Coverage
- Not disclosed
- Brand-name
- Compounded only
Semaglutide · modeled / year
$1,788
Tirzepatide · modeled / year
$2,388
Pricing verified September 2026
The Index scorecard
Science & Co scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
- Its own FAQ names the commitment behind the headline: "Plans start at $79 a month on the 12 month plan"
- The printed saving corroborates the reference price — 79 divided by 149 is 53%, exactly the "Save 47%" shown
- Names its operating entity and state of incorporation, and says every batch is third-party tested
The tradeoffs
- The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
- It says it is not a compounding facility but never names the pharmacy that is
- Injection only on the pages read, and no brand-name lane
The bottom line
Best for: A twelve-month committer, or someone who values a company stating plainly what it is and is not. Declares in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two disclosures most of this market never makes.
Ranked #62 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Science & Co.
- #50NiceRx— NiceRx is a compounded GLP-1 telehealth platform charging $199/mo for semaglutide and $299/mo for tirzepatide on an ongoing month-to-month basis (first month discounted to $99 and $199 respectively).76/100
- #51Vytora Health— Vytora Health (Wasef Health, PC) is a 50-state-plus-DC telehealth platform selling flat-rate compounded semaglutide and tirzepatide alongside retail-priced brand-name Mounjaro and Zepbound ($1,399/mo each).76/100
- #52Rylo Health— Rylo Health is a compounded GLP-1/NAD+/peptide telehealth platform operating in all 50 states through Lone Star Virtual Health PLLC and dispensing via VialsRX in Houston, TX.75/100
- #53Synergy Rx— Brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock clinical contact — at prices its own site never shows.72/100
- #54Peter MD— One account across six verticals — TRT, ED, weight loss, GLP-1, men's hair loss and NAD+ — from a physician-prescribed telehealth brand running since 2021, at a renewal price ($249/mo tirzepatide) well above its own $149 first-month headline.72/100
- #55EdgeRx— The best clinical documentation of any newly added row — a named Chief Medical Advisor and a named 503A pharmacy — but it's a men's-only platform, not a fit for every reader.74/100
The 24 programs nearest this one
- #63 Gala Health71
- #64 Direct Meds71
- #65 He & She MD71
- #66 SkinnyRx71
- #67 Amazon One Medical73
- #68 MyFastRx73
- #69 Navio MD73
- #70 Ozari Health73
- #71 Trillium Meds73
- #72 Clume Health73
- #73 BiltRx72
- #74 Candor Rx72
- #75 Get Thin MD72
- #76 Heally72
- #77 Recovery Delivered72
- #78 Nova72
- #79 Bodybuilding Health+69
- #80 Apex MD71
- #81 GOAL.MD71
- #82 Queen RX71
- #83 Rivo Health71
- #84 Goldspan Health71
- #85 altRX70
- #86 Bionomy Health70
Pricing, states and verification reflect Science & Co's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Science & Co's site. Not medical advice; see our disclosure.